GlassScriptPhysician profile
Natasha Beverage
NPI 1679202329
$2,716.74
in general payments reported to CMS, 2019-2025
16 companies · $1,505 in 2025
The $1,505 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $456 · 2024: $572 · 2025: $1,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Travel and Lodging: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.91 |
| Travel and Lodging | $914.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,116.12 | 2025 | |
| Kerecis Limited | $250.03 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Convatec INC. | $210.39 | 2023-2024 | |
| Nevro Corp. | $206.98 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $153.96 | 2022-2025 | Grafix Pl, Stravix |
| Nexus Medical Technologies LLC | $140.83 | 2025 | |
| Paratek Pharmaceuticals, INC. | $137.08 | 2023 | Nuzyra |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $118.95 | 2024 | Physio-Stim |
| Boston Scientific Corporation | $60.16 | 2022 | |
| Organogenesis INC. | $59.57 | 2024-2025 | Puraply Wound Matrix, Apligraf |
| Rock Medical Orthopedics, INC. | $45.84 | 2023 | |
| Polynovo North America LLC | $29.08 | 2024 | Novosorb Btm |
| Averitas Pharma INC. | $23.93 | 2025 | Qutenza |
| Stryker Corporation | $23.18 | 2024 | Actishield, Citrefix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.65 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Beverage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.